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Although diﬀerent statistical approaches have been proposed for analyzing microarray time-course data, method for analyzing
such data collected using the popular case–control design in clinical investigations has not been proposed perhaps due to the in-
creased complexity for the existing parametric or non-parametric approaches. In this paper, we introduce a new multivariate data
analyzing technique, the correspondence analysis, to analyze the high dimensional microarray time-course data in case–control
design. We show, through an example on type 2 diabetes, how the nice features of the correspondence analysis can be use to explore
the various time-course gene expression proﬁles that exist in the data. By coordinating and examining the projections on the reduced
dimensions by both the genes and the time-course experiments, we are able to identify important genes and time-course patterns and
make inferences on their biological relevance. Using the sample replicates, we propose a bootstrap procedure for inferring the
signiﬁcance of contributions on the leading dimensions by both the time-course experiments and the genes. Striking diﬀerences in the
time-course patterns in the normal controls and diabetes patients have been revealed. In addition, the method also identiﬁes genes
that display similar or comparable time-course expression patterns shared by both the cases and the controls. We conclude that our
correspondence analysis based approach can be a useful tool for analyzing high dimensional microarray data collected in clinical
investigations.
 2004 Elsevier Inc. All rights reserved.
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The last century witnessed great advances in the
identiﬁcation of single gene disorders. Nowadays as
complex diseases are becoming a major thread to our
health, unraveling the genetic clues to complex diseases
is going to be a more challenging task for the whole ﬁeld
of biomedicine [1]. As complex diseases are of polygenic
nature, the microarray technology capable of measuring
the expression of thousands of genes is a useful tool in
helping us to investigate the genetic domain in the eti-
ology of complex disorders [2,3]. At the same time, in-* Corresponding author. Fax: +45-65411911.
E-mail address: qihua.tan@ouh.fyns-amt.dk (Q. Tan).
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doi:10.1016/j.jbi.2004.06.001terpreting the large amount of data generated by
microarray experiments has become a tough issue con-
fronting the researchers [4–6]. Among the major chal-
lenges is the analysis on microarray data produced by
the time-course experiments designed to study the bio-
logical process and the regulatory networks that un-
derline the genetic basis in the development of complex
diseases.
Although still an issue under investigation, there has
been noticeable progress in developing statistical meth-
ods to handle time-course data. As one of the earliest
application, the simple clustering method has been used
[7]. Xu et al. [8] introduced a regression-based method to
time-course data to incorporate the time-varying co-
factors in the analysis which the cluster analysis failed to
do. Other model-based approaches include the linear
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proposed tests based on the analysis of variance (AN-
OVA) model which requires normality assumption on
the expression level or computer intensive permutations.
As the biological systems are usually dynamic and in-
teractive, we think that a useful method should be able
to capture and present the diverse expression patterns in
a way that is least dependent on any predeﬁned math-
ematical model or statistical distribution. This is espe-
cially crucial in case of time-course data collected from
clinical case–control studies due to the complexity in (1)
increased dimensionality and (2) diﬀerential and dy-
namic gene expression proﬁles that underline the genetic
background in the disease etiology.
Correspondence analysis (CA) is a technique for
studying the associations among a set of variables by
graphically displaying the patterns and structures ex-
isting in the data which serves as a window onto the
data [12]. The method has been widely applied to
multivariate data analysis in, for example, sociology,
environmental science, and marketing research. Fellen-
berg et al. [13] introduced the method to the analysis of
microarray data by displaying the associations between
genes and experiments. The method is capable of pro-
jecting genes in the hybridization space and hybridiza-
tions in the space of genes thus revealing the association
between the two variables and the association within
genes or hybridizations. In this paper, we explore the
feasibility of applying the method to deal with high
dimensional microarray data produced in time-course
experiments in case–control studies through an example
from a microarray study on type 2 diabetes. Combined
with a bootstrap procedure using sample replicates, we
show how the nice feature of CA can be used to iden-
tify, conditional on the disease status, the diﬀerential
time-course expression proﬁles in response to insulin
stimulation characterized by the dynamic regulation of
top rank genes. Besides, the method also helps us to
ﬁnd shared time-course gene expression patterns that
exist in both the diabetes patients and the normal
controls. The signiﬁcance of our approach in micro-
array data analysis in clinical studies is discussed at the
end of the presentation.2. Materials and methods
2.1. Gene expression data
In a recent study aimed at investigating the diﬀeren-
tial mRNA expression proﬁles in response to insulin
stimulation between type 2 diabetes patients and normal
controls [14], extracted messenger RNA from cultured
skeletal muscle cells donated by 4 subjects (2 patients
and 2 controls) were hybridized to Aﬀymetrix U95Av2
chips (each containing 12,600 genes or probe-sets) at 7time-points (0, 1/2, 1, 2, 4, 8, and 24 h) of insulin incu-
bation. The experiments resulted in a total of 28 chips
(14 in patients and in controls each) expanding the
seven time points (contact Lars Hansen at larh@
novonordisk.com for more on the data).
2.2. Data normalization
Data are ﬁrst normalized to adjust or scale the overall
intensity across the hybridizations (both in the cases and
in the controls at the 7 time-points) to ensure that the
arrays are comparable. To do this, the array with me-
dian overall intensity is chosen as the baseline array such
that other arrays are normalized against it. The invari-
ant set normalization method [15] is used for the nor-
malization at the probe level.
2.3. Gene expression value calculation and gene ﬁltering
Because the normalized intensities are at probe level,
we use the model-based approach [16] to summarize the
expression value for each gene or probe-set on each
chip. Genes are then ﬁltered by dropping those that
show only low intensities and whose expressions fail to
vary across the samples. Following Li and Wong [17],
we select (1) genes that were detected as present in all the
arrays; (2) genes whose expression values P20; and (3)
the ratio between the standard deviation and the mean
of a gene’s expression value across all samples P0.15.
This results in a total of 2872 genes for subsequent
analysis. From the replicates at each time-point, we
obtain the mean expression values for each gene in the
patients and in the controls at that time-point. This
produces a large matrix of mean gene expression values
with rows standing for the genes and columns for the
time-course experiments in the diabetes and in the nor-
mal controls. In addition, we form for each of the four
subjects a matrix containing expressions by genes (in
rows) at the 7 time-points (in columns) for use in the
bootstrapping.
2.4. Correspondence analysis
As a multivariate method, correspondence analysis
summarizes high-dimensional data into a low-dimen-
sional space while maintaining the main information by
representing the maximum variability in the dataset by
principal factors [18]. Since CA was primarily designed
for analyzing contingency tables, it can reveal the as-
sociation both between and within all the variables si-
multaneously. The application of CA to microarray
data has helped to explore the two way intricateness
between genes and experiments [13] or tissue types [19].
By combining variables, CA can be extended to ana-
lyzing multiple-table data [20], for example, the space-
time multivariate data in environmental studies [21].
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croarray time-course data collected using the typical
case–control design in clinical studies by associating the
time-course experiments with gene expression proﬁles
conditional on the disease status.
The algorithm is briefed as follows. We ﬁrst divide
each entry or element in our data matrix of mean gene
expression by the total of the matrix so that the sum of
all the entries in the resulted matrix is equal to 1. We
denote the matrix by P and its elements by pijk (i stands
for the genes from 1 to n, j for the time-points from 1 to
m and k for the disease status with k ¼ 0 for control and
k ¼ 1 for disease). In matrix P , the sum of row i (or
mass) is pi: ¼
P
k
P
j pijk and that for the column for
time-point j in group k is p:jk ¼
P
i nijk . pi: and p:jk are
used to calculate the expected value for each element in
matrix P , p0ijk ¼ pi:p:jk . We then derive a new matrix C
with elements cijk ¼ ðpijk  p0ijkÞ=
ﬃﬃﬃﬃﬃﬃﬃ
p0ijk
q
[13]. Matrix C is
submitted to singular value decomposition (SVD) which
transfers it into the product of three matrices, i.e.,
C ¼ UKV 0. Here, U stands for the eigenvectors of CC0
and V for the eigenvectors of C0C, K is a diagonal matrix
containing the eigenvalues of C. The elements of K, kl
(l ¼ 1; 2; . . . ; 2m) can be ranked. The top elements
(usually two or three) that dominate the total inertiaP
l k
2
l , represent the axes that account for the major
variations in the original data leading to dimension
reduction.
2.4.1. Projection and biplot
With the above matrices, U , V , and K, we can project
our data into a new space. In the new space, projection
of gene i on axis l is gil ¼ kluil= ﬃﬃﬃﬃﬃpi:p where uil represents
the lth column in U . Similarly, the projection of
time-point j in the disease status k on axis l is
hjkl ¼ klvjkl= ﬃﬃﬃﬃﬃﬃﬃp:jkp , where vjkl is the lth column in V .
Examining projections on the leading axes in the new
space can help (1) to understand the biological or ex-
perimental meanings that underline each of the axes and
(2) to ﬁnd genes whose expressions are diﬀerentially
regulated under speciﬁc experimental conditions (for
example, genes highly expressed at certain time-points in
a given disease status) which is the merit of correspon-
dence analysis. A very useful tool for visualizing the
data for the above proposes is the biplot. As indicated
by its name, a biplot displays the relationships both
between the time-points conditional on the disease sta-
tus by their variances/covariances and between the genes
by plotting their projections on two independent di-
mensions. By simultaneous inspection on a biplot, one
can easily identify genes that are up-regulated at certain
time-points in a given disease status.
2.4.2. Contributions
The inertia along the lth axis can be decomposed into
components for each gene, i.e., k2l ¼
P
i pi:g
2
il. From this,we can calculate the absolute contribution of the ith
gene to the lth axis as, acil ¼ pi:g2il=k2l . The contribution
is the proportion of the inertia of the lth axis explained
by the ith gene. Genes with relatively large contributions
are more important in determining the direction of the
axis concerned. If there are n genes on the chip, for each
gene a mean contribution of 1/n would be expected in
the case of a purely random distribution of genes over
that axis. In our case, the mean of the random contri-
bution is about 0.0003 (1/2872) which applies to all the
dimensions in the new space. In the same manner, we
can calculate the contribution of the jth time-point in
disease status k to the lth axis as acjkl ¼ p:jkh2jkl=k2l . Since
there are altogether 14 time-point experiments, we set
the random mean to 0.07 (1/14). The random means for
both the genes and the time-course experiments will be
used for signiﬁcance inferences in the subsequent boot-
strapping procedure.
2.4.3. Non-parametric bootstrapping
The above procedure estimates the contribution for
each gene and for each time-course experiment on the
leading dimensions in the new space. However, as a
descriptive method it does not test the statistical signif-
icance of the contributions and thus oﬀers no way for
discriminating the estimated contributions from random
eﬀects. Using sample replicates, Kerr and Churchill [22]
proposed a bootstrap procedure for assessing pattern
reliability based on the estimated error distribution in
their ANOVA models [23]. Following their idea, we
introduce the bootstrap technique to assess the statisti-
cal signiﬁcance of the estimated contributions. To do
this, we randomly pick up with replacement one ex-
pression value of a gene at each time-point from the two
control replicates and the two diabetic replicates to form
a bootstrap matrix with rows standing for the genes and
columns for the time-course experiments in the cases
and the controls. A bootstrap sample that resembles the
mean gene expression matrix in Section 2.3 is obtained
by taking the mean gene expression from two bootstrap
matrixes. The bootstrap sample is submitted to the
correspondence analysis procedure described above and
the contributions on the leading dimensions by each
gene and each time-course experiment recorded. When
this process is repeated B times, we obtain the bootstrap
p-value for comparing the estimated contribution with
the mean random contribution as p PBj¼1
Iðacj6 acrandomÞ=B, where IðÞ is the indicator function,
acj is the absolute contribution estimated for each gene
in bootstrap sample j, and acrandom is the mean random
contribution.
2.4.4. Gene expression proﬁling
Based on the signiﬁcance level, we can select genes
that highly contribute to determining the major dimen-
sions and in addition examine their time-course
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diabetes patients separately. This is done by plotting the
scaled gene expression intensity against the time-points
for the genes selected. To present the diﬀerent time-
course patterns, we group the genes according to their
closely associated time-points that characterize or direct
the corresponding axes as indicated in the biplots. As to
be shown later in Section 3, this will help to identify
groups of genes that display similar or dissimilar time-
course patterns in the patients and the controls. Diﬀer-
ential gene expression proﬁles conditional on the disease
status can be studied together with the genes concerned
to further explore the biological pathways involved in
the disease development.
2.5. Software
All calculations in correspondence analysis were done
by programming using the freely available R package
(http://www.r-project.org) and by deploying the corre-
spondence analysis procedure in the multiv package for
R. All R procedures for calculation and bootstrapping
are available upon request.3. Results
By applying the method described above to our dia-
betes time-course data, we found that the ﬁrst axis ac-
counts for 61% of the total inertia, the second and the
third for 16 and 11%, respectively, which accumulate to
77 and 88%. As a result of dimension reduction, the ﬁrst
two or three axes catch up main variations in the ori-Fig. 1. Biplots showing projections by both genes and time-course experimen
axes. While the ﬁrst axis is characterized by the disease status, the second a
independent of disease status as indicated by the symmetric sequence of timginal data. Fig. 1 is the biplots showing the projections
on the ﬁrst axis against that on the second (Fig. 1A) and
the third (Fig. 1B) axes both by the genes and by the
time-course experiments (diabetes labeled with ‘‘d’’ and
control with ‘‘c’’ followed by a sequence number for
time-points from 1 to 7 representing 0, 1/2, 1, 2, 4, 8, and
24 h after insulin stimulation). In Fig. 1, all the time-
points in the diabetes experiments are projected to the
left and all that in the control experiments are to the
right over the ﬁrst axis indicating that the ﬁrst axis
features the disease status. As to be shown later, the
ﬁgure also suggests that the ﬁrst axis is mainly domi-
nated by genes highly expressed at time-points 1, 2, and
3 in the diabetic patients. It is interesting to look at the
projections of time-points on the second axis in Fig. 1A.
The three early time-points after insulin stimulation (1/2,
1, and 2 h) are all projected below zero over the second
axis both in the diabetes and in the controls. The end
time-points after insulin stimulation (4, 8, and 24 h),
together with the ﬁrst time-point (no stimulation), are
all projected above zero over the second axis again in
both the diabetes and the controls (except for c5 whose
projection is nearly zero). This means that the second
axis mainly distinguishes genes up-regulated in early
response to insulin stimulation from genes that go the
opposite way but resume their expression activities back
to the pre-stimulation level at the end. Although the
time-course patterns that characterize the second axis
exist regardless of the disease status, they are more
pronounced in the diabetes patients than in the controls
as indicated by the larger spreading of time-points on
the left side of Fig. 1A than that on the right. One can
clearly see that the spanning of the second axis is mainlyts over the ﬁrst axis against that over the second (A) and the third (B)
nd the third axes convey shared time-course gene expression patterns
e-points spreading over the second and the third axes.
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along the axis which also lay on the diabetes side over
the ﬁrst axis. With time-point 3 projected at the center,
the third axis describes additional time-course patterns
shared both by the patients and by the controls
(Fig. 1B). The biplot shows that genes up-regulated after
2 h of insulin stimulation (late response when compared
with genes coordinated to below zero over the second
axis in Fig. 1A) are projected to above zero over the
third axis. The opposite side represents genes that
maintain their pre-stimulation expression level until half
hour after the stimulation and then turned down but
tend to resume their activities at the end of the observed
time-course.
The relative importance of each gene or time-point on
a leading dimension in the new space is evaluated by
estimating its corresponding contribution on that axis.
Using the replicate data, we apply the bootstrap pro-
cedure to obtain an empirical distribution of the con-
tribution. A total of 30,000 bootstrap samples were
generated to ensure high precision in evaluating the
signiﬁcance. In Fig. 2, we show the empirical distribu-
tions of contribution by the seven time-points on the top
three axes in the diabetic patients and the normal con-
trols using the boxplot. When no signiﬁcant time-course
pattern exists, all the boxes should be centered round the
mean random contribution indicated by the dashed
horizontal line. However, Figs. 2A and B show clear
deviation from the random contribution as most of the
ranges of the bootstrap contribution do not cover the
random mean. Moreover, for all the time-points in Figs.
2A and B, striking diﬀerences in their contributions toFig. 2. Boxplots showing the distributions of time-point contributions on the
disease status are revealed (A and B) while similar time-course patterns uncthe ﬁrst axis are observed between the patients and the
controls as almost at each time-point, the empirical
ranges of contribution for the two groups (patients and
controls) do not overlap. In Figs. 2A and B, the opposite
and nonrandom patterns in the time-course contribution
conditional on the disease status give a clear indication
that the ﬁrst axis conveys important information on
genes that are diﬀerentially regulated in the patients and
the controls during the time-course experiments. Dif-
ferent from Figs. 2A and B, most of the empirical ranges
of time-course contributions in Figs. 2C–F cover the
mean random contribution marked by the dashed hor-
izontal line indicating the lower signiﬁcance level of
contributions on the second (Figs. 2C and D) and the
third (Figs. 2E and F) axes. Furthermore, the contri-
butions at each time-point in the disease and the control
groups overlap suggesting that there are genes that show
similar or comparable time-course expression patterns
independent of the disease status. It is interesting to see
that the time-point contributions in Figs. 2C and D even
show a comparable pattern over the time-course al-
though the overall pattern in the diabetic patients is
shifted up which is consistent with the expectation from
Fig. 1A.
We assess the signiﬁcance of contribution on a lead-
ing axis for each gene using the bootstrap distribution as
described in Section 2.4. Genes are ranked by their
signiﬁcance levels in their contributions on each of the
ﬁrst three axes and top genes are selected for a given
signiﬁcance level. In Fig. 3 we show the time-course
expression proﬁles for the selected genes. As indicated
by Figs. 2A and B, we found the same groups of genesﬁrst three axes. Diﬀerential time-point contributions conditional on the
onditional on the disease status are suggested (C–F).
Fig. 3. The observed time-course expression patterns in diabetes patients and in normal controls for diﬀerent groups of selected genes. The plots
display the diﬀerential time-course proﬁles conveyed by the ﬁrst axis (A–D) and the shared proﬁles over the second (E–H) and the third (I–L) axes.
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course expression patterns in Figs. 3A and B (49 genes)
and Figs. 3C and D (51 genes) which characterize the
disease status. At the same time, as suggested by Figs.
2C–F, we found the same groups of genes (p < 0:0005)
demonstrating similar or comparable time-course pro-
ﬁles in Figs. 3E and F (3 genes), Figs. 3G and H (32
genes), Figs. 3I and J (19 genes) and Figs. 3K and L (26
genes). Our results reveal that in addition to the genes
diﬀerentially regulated in response to insulin stimulation
in the diabetic patients and the normal controls, there
are also genes, although less signiﬁcant than the genes in
Figs. 3A–D, exhibiting similar expression patterns over
the time-course unconditional on the disease status.4. Discussion
The application of correspondence analysis to our
diabetes data has produced results that reveal both dif-
ferential and similar time-dependent gene expression
proﬁles in response to insulin stimulation conditional on
the disease status. The diﬀerent time-course patterns in
Figs. 3A–D display the high gear gene activities trig-
gered by insulin stimulation in the diabetic muscle but
which keep falling down over the time-course. Pathway
analysis using the KEGG database has found that the
top genes are signiﬁcantly involved in glycolysis, bile
acid biosynthesis, fatty acid metabolism, glycerolipid
metabolism, and pentose phosphate pathways suggest-
ing the important role of oxidative phosphorylation andmetabolism in the diabetes pathogenesis [24,25]. The
various shared patterns independent of disease status
could also suggest that there are important insulin re-
lated biological processes that are intact in the diabetic
muscle.
Diﬀerent statistical methods have been proposed to
deal with microarray time-course data [26]. However,
none has addressed the situation of a time-course study
in the case–control design which is typical in clinical
investigations perhaps due to the increased complexity
in the data structure. To simplify the situation, one
could work with the ratio between the disease and the
control for each gene and at each time-point. However,
such a practice could (1) double the variance at each
time-point and thus, in case of a small sample size which
is usually true for microarray studies, make the time-
dependent patterns untraceable; (2) result in some
strange patterns that are meaningless or diﬃcult to ex-
plain because such patterns are indirect and lack speci-
ﬁcity (the same pattern can be resulted from the ratio of
many diﬀerent original proﬁles); and (3) hide the shared
patterns as revealed by the second and the third axes in
our analysis because the ratio cancels out the original
dynamic proﬁles. As a non-parametric method, corre-
spondence analysis works without imposing any pre-
conceptions on the data. It not only simpliﬁes the
modeling process but also enables direct visualization of
the various dynamic proﬁles that dominate the full ga-
mut of variations in the data.
As discussed by Kerr and Churchill [22], replication
in microarray experiment not only increases the preci-
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information on their variability. Following the spirit of
Kerr and Churchill [22], we have shown that the boot-
strap technique can also be applied to correspondence
analysis with replicate samples for assessing the signiﬁ-
cance of contribution by each gene and by each time-
course experiment. This enables us to select important
genes with consideration of variation or reliability in
their contributions. At the same time, the bootstrap
distribution of the contribution by each time-course
experiment as shown by the boxplot in Fig. 2 assists us
to judge if the contribution by each time-course exper-
iment is signiﬁcantly diﬀerent from random. Moreover,
comparing the bootstrap distribution of contributions at
certain time-point in the diabetic patients and the nor-
mal controls can help us to infer if similar or dissimilar
time-course expression proﬁles exist in the two groups
which is crucial in case–control microarray studies.
Normality has been a common assumption for data
analysis by many traditional statistical approaches. Such
assumption amounts to a constant variance independent
of the mean in the data, a situation usually violated in
microarray data [27]. Diﬀerent variance stabilization
methods have been proposed to transform the data such
that analyses by standard statistical procedures can be
performed [27–29]. Although the data requirement for
correspondence analysis is highly ﬂexible, it is necessary
to point out that the non-parametric method also helps
to standardize the variance in the data. In our analysis,
the individual elements in matrix C which is submitted
to SVD can be viewed as the standardized residuals.
Such an algorithm helps to compensate for the larger
variance in genes with stronger signals and the smaller
variance in the genes with weaker signals. This nice
feature serves as an additional way to alleviate the
intensity-dependent variance problem in microarray
data [27].
It is necessary to describe the operating characteris-
tics of our approach and compare with the other existing
methods that deal with microarray time-course data. As
a non-parametric approach, our method does not make
any assumption on the distribution of the microarray
expression data which is distinct from the existing
parametric methods [11]. Moreover, using the bootstrap
procedure, our method infers statistical signiﬁcance
without relying on any statistical distribution of the es-
timates (contributions). Other non-parametric methods
exist in the literature [30,31], however, those methods
are not yet readily applicable for analyzing the high
dimensional time-course data in case–control design for
which we are interested not only in identifying the var-
ious time-dependent patterns but also in verifying the
diﬀerential proﬁles dependent on the disease status. As
singular value decomposition is a popular tool for di-
mension reduction, our SVD based procedure is inher-
ently capable of dealing with high dimensionalmicroarray data in complex design that arise in clinical
investigations, for example, the time-course or dose–
response data for diﬀerent cell lines, treatment groups,
subtypes of a disease or trait. By correspondence anal-
ysis, we choose to work on the reduced leading dimen-
sions that account for the major variations in the data to
pick up important similar or dissimilar time-course
patterns conveyed by the top axes conditional on the
disease phenotypes. In addition, unlike some clustering
procedures that require pre-deﬁned candidate proﬁles
[32,33] which are exempted from the analysis, our ap-
proach let the data speak for itself in pattern identiﬁ-
cation and compares bootstrap distribution of the
contribution by each time-point for given disease status
(Fig. 2) which is clinically meaningful.
In our application, we are focusing on case–control
data with aim at ﬁnding disease-dependent and inde-
pendent gene expression time-course patterns. We are
considering combining our bootstrap procedure with
correspondence analysis to apply to microarray experi-
ments designed for discriminating sub-groups in a
complex disease. In this case, correspondence analysis
can be used to classify the samples according to the
diﬀerent expression proﬁles that characterize the various
subtypes of the disease. With sample replicates, the
bootstrap procedure can help to validate the classiﬁca-
tions. This is important as microarray is playing an in-
creasingly important role in disease diagnosis,
classiﬁcation and treatment evaluation [34].Acknowledgments
The authors are grateful to both of the two anony-
mous referees and the editor for their valuable com-
ments as well as constructive suggestions that helped to
strengthen the paper. This work was jointly supported
by the ‘‘MicroArray Center’’ project under the bio-
technological research program ﬁnanced by the Danish
Research Agency, the Danish Medical Research Coun-
cil, the Novo-Nordisk Foundation, and the Clinical
Institute at OUH. We also thank Irene Lynfort for
providing excellent technical assistance and Kurt Høj-
lund for the muscle biopsies.References
[1] Risch NJ. Searching for genetic determinants in the new millen-
nium. Nature 2000;405:847–56.
[2] Lander ES. Array of hope. Nat Genet 1999;21:S3–4.
[3] Brown PO, Botstein D. Exploring the new world of the genome
with DNA microarrays. Nat Genet 1999;21:S33–7.
[4] Bassett DE, Eisen MB, Boguski MS. Expression informatics-it’s
all in your mind. Nat Genet 1999;21:S51–5.
[5] Slonim DK. From patterns to pathways: gene expression data
analysis comes of age. Nat Genet 2002;32:S502–8.
Q. Tan et al. / Journal of Biomedical Informatics 37 (2004) 358–365 365[6] Nadon R, Shoemaker J. Statistical issues with microarrays:
processing and analysis. Trends Genet 2002;18:265–71.
[7] Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis
and display of genome-wide expression patterns. Proc Natl Acad
Sci USA 1998;95:14863–8.
[8] Xu XL, Olsen JM, Zhao LP. A regression-based method to
identify diﬀerentially expressed genes in microarray time course
studies and its application in an inducible Huntington’s disease
transgenic model. Hum Mol Genet 2002;11:1977–85.
[9] De Hoon MJL, Imoto S, Miyano S. Statistical analysis of a small
set of time-ordered gene expression data using linear splines.
Bioinformatics 2002;18:1477–85.
[10] LuanY,LiH.Clusteringof time-coursegene expressiondatausinga
mixed-eﬀectsmodel withB-splines. Bioinformatics 2003;19:474–82.
[11] Park T, Yi S, Lee S, Lee SY, Yoo D, Ahn J, Lee Y. Statistical tests
for identifying diﬀerentially expressed genes in time-course
microarray experiments. Bioinformatics 2003;19:694–703.
[12] Everitt BS, Dunn G. Applied multivariate data analysis. 2nd ed.
London: Arnold press; 2001.
[13] Fellenberg K, Hauser NC, Brors B, Neutzner A, Hoheisel JD,
Vingron M. Correspondence analysis applied to microarray data.
Proc Natl Acad Sci USA 2001;98:10781–6.
[14] Hansen L, Gaster M, Oakeley E, Brusgaard K, Nielsen ED, Beck-
Nielsen H, Pedersen O, Hemmings B. DNA chip analysis of
human myotubes from type 2 diabetic and glucose-tolerant
control subjects: kinetics of insulin regulated mRNA expression
in vitro (submitted).
[15] Li C, Wong WH. Model-based analysis of oligonucleotide arrays:
model validation, design issues and standard error application.
Genome Biol 2001;2, research0032.1–0032.11.
[16] Li C, Wong WH. Model-based analysis of oligonucleotide arrays:
expression index computation and outlier detection. Proc Natl
Acad Sci USA 2001;98:31–6.
[17] Li C, Wong WH. DNA-Chip Analyzer (dChip). In: Parmigiani G,
Garrett ES, Irizarry R, Zeger SL, editors. The analysis of gene
expression data: methods and software. NewYork: Springer; 2003.
[18] Greenacre MJ. Theory and applications of correspondence
analysis. 1st ed. London: Academic Press; 1984.
[19] Kishino H, Waddell PJ. Correspondence analysis of genes and
tissue types and ﬁnding genetic links from microarray data.
Genome Inform 2000;11:83–95.
[20] Clausen S. Applied correspondence analysis. Thousand Oaks, CA:
SAGE publications; 1998.[21] Palma M. Correspondence Analysis on a space-time data set for
multiple environmental variables. In: Proceedings of the Annual
Conference of the International Association for Mathematical
Geology, IAMG2001, Cancun, Mexico, September 6–12; 2001.
[22] Kerr MK, Churchill GA. Bootstrapping cluster analysis: assessing
the reliability of conclusions from microarray experiments. Proc
Natl Acad Sci USA 2001;98:8961–5.
[23] Kerr MK, Martin M, Churchill GA. Analysis of variance for gene
expression microarray data. J Comput Biol 2000;7:819–37.
[24] Busch CP, Hegele RA. Genetic determinants of type 2 diabetes
mellitus. Clin Genet 2001;60:243–54.
[25] Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpha-
responsive genes involved in oxidative phosphorylation are
coordinately downregulated in human diabetes. Nat Genet
2003;34:267–73.
[26] Schliep A, Schonhuth A, Steinhoﬀ C. Using hidden Markov
models to analyze gene expression time course data. Bioinfor-
matics 2003;19:I255–63.
[27] Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron
M. Variance stabilization applied to microarray data calibration
and to the quantiﬁcation of diﬀerential expression. Bioinformatics
2002;18:S96–104.
[28] Durbin BP, Hardin JS, Hawkins DM, Rocke DM. A variance-
stabilizing transformation for gene-expression microarray data.
Bioinformatics 2002;18:S105–10.
[29] Durbin BP, Rocke DM. Variance-stabilizing transformations for
two-color microarrays. Bioinformatics 2004;20:660–7.
[30] Phang TL, Neville MC, Rudolph M, Hunter L. Trajectory
clustering: a non-parametric method for grouping gene expression
time courses, with applications to mammary development. Pac
Symp Biocomput 2003:351–62.
[31] Peddada SD, Lobenhofer EK, Li L, Afshari CA, Weinberg CR,
Umbach DM. Gene selection and clustering for time-course and
dose–response microarray experiments using order-restricted in-
ference. Bioinformatics 2003;19:834–41.
[32] Chu S, DeRisi J, Eisen M, Mulholland J, Botstein D, Brown PO,
Herskowitz I. The transcriptional program of sporulation in
budding yeast. Science 1998;282:699–705.
[33] Heyer LJ, Kruglyak S, Yooseph S. Exploring expression data:
identiﬁcation and analysis of coexpressed genes. Genome Res
1999;9:1106–15.
[34] Rouse R, Hardiman G. Microarray technology—an intellectual
property retrospective. Pharmacogenomics 2003;4:623–32.
